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The fine control of molecules mediating communication in the nervous system is key
to adjusting neuronal signaling during development and in maintaining the stability of
established networks in the face of altered sensory input. To prevent the culmination
of pathological recurrent network excitation or debilitating periods of quiescence,
adaptive alterations occur in the signaling molecules and ion channels that control
membrane excitability and synaptic transmission. However, rather than encoding (and
thus “hardwiring”) modified gene copies, the nervous systems of metazoa have opted
for expanding on post-transcriptional pre-mRNA splicing by altering key encoded amino
acids using a conserved mechanism of A-to-I RNA editing: the enzymatic deamination
of adenosine to inosine. Inosine exhibits similar base-pairing properties to guanosine
with respect to tRNA codon recognition, replication by polymerases, and RNA secondary
structure (i.e.,: forming-capacity). In addition to recoding within the open reading frame,
adenosine deamination also occurs with high frequency throughout the non-coding
transcriptome, where it affects multiple aspects of RNA metabolism and gene expression.
Here, we describe the recoding function of key RNA editing targets in the mammalian
central nervous system and their potential to be regulated. We will then discuss how
interactions of A-to-I editing with gene expression and alternative splicing could play
a wider role in regulating the neuronal transcriptome. Finally, we will highlight the
increasing complexity of this multifaceted control hub by summarizing new findings from
high-throughput studies.
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A-TO-I RNA EDITING IN THE VERTEBRATE
NERVOUS SYSTEM
Although progress has been made in characterizing the functions
of invertebrate editing sites, the challenge of understanding the
true scale and roles of RNA editing in regulating neurophysiol-
ogy in higher vertebrates continues at a somewhat slower pace.
In particular, the impact of editing in non-coding regions, which
harbor the vast majority of editing sites (see below) is not known.
Base changes via RNA editing expand on the central dogma of
molecular biology by readjusting the genetic code at the RNA
level in order to substitute amino acids (Rosenthal and Seeburg,
2012). Remarkably, this occurs at functionally critical positions
in targets mediating synaptic transmission. For example, editing
of the α3 subunits of GABAA receptor ion channels modulates
agonist potency and receptor gating properties to tune inhibition
(Ohlson et al., 2007; Rula et al., 2008). Similarly, at excitatory
synapses A-to-I editing is responsible for a number of recod-
ing events in many of the non-NMDA glutamate receptor ion
channel subunits (AMPA GluA2, 3, 4, and kainate GluK1, 2;
Sommer et al., 1991; Köhler et al., 1993; Lomeli et al., 1994),
including the efficient Q/R site conversion of GluA2, which gates
calcium permeability and receptor trafficking that are essential
for survival (Sommer et al., 1991; Burnashev et al., 1992; Brusa
et al., 1995; Greger et al., 2002). More generally, membrane
excitability is modified by A-to-I editing of select subunits of
voltage-gated potassium (Kv1.1) and calcium (Cav1.3) channels
resulting in altered channel inactivation properties (Bhalla et al.,
2004; Huang et al., 2012). Neuromodulatory control by serotonin
is also targeted, where A-to-I editing of the metabotropic recep-
tor 5-HT2C attenuates coupling to its G-protein secondmessenger
system (Burns et al., 1997). Furthermore, editing could also reg-
ulate serotonin signaling more globally by modifying activity of
the enzyme tryptophan hydroxylase-2 (TPH2, Grohmann et al.,
2010), which is rate-limiting for serotonin synthesis in the brain
(Zhang et al., 2004). As the list of non-synonymous codon-
changes in neuron-related transcripts continues to grow (e.g.,
Danecek et al., 2012), it appears that A-to-I RNA editing is poised
to directly tune the function of key nervous system components.
This is particularly evident in invertebrates where recoding sites
are more frequent and where functional changes have been eluci-
dated (e.g., Rosenthal and Bezanilla, 2002; Hoopengardner et al.,
2003; Colina et al., 2010). In fact, a recent study showed that
editing of delayed rectifier potassium channels mediates temper-
ature adaptation (Garrett and Rosenthal, 2012) to compensate
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for an overall slower signaling at low temperatures, editing accel-
erates gating kinetics of this potassium channel in Arctic and
Antarctic squid species relative to their tropical relatives (Garrett
and Rosenthal, 2012). Invertebrate RNA editing is beyond the
scope of our discussion and so we refer the reader to some
recent reviews (Jepson and Reenan, 2008; Rieder and Reenan,
2012).
DEVELOPMENTAL REGULATION OF A-TO-I EDITING
The deamination reactions responsible for A-to-I editing are cat-
alyzed by a family of “editases”: adenosine deaminases acting
on RNA (ADARs). The relatively high inosine content of brain
mRNA (Paul and Bass, 1998), seizure susceptibility and lethal
neurological phenotype of ADAR2 knockout mice (Higuchi et al.,
2000), and the overall more selective expression of ADARs in the
nervous system suggest that A-to-I editing contributes to refin-
ing neuronal function in development and during adult forms
of synaptic plasticity. Developmental elevation of editing at vari-
ous sites for many coding targets has been shown recently using
new high-throughput sequencing technologies (Wahlstedt et al.,
2009). These findings concur with earlier, more detailed studies
on specific sites (e.g., Bernard and Khrestchatisky, 1994; Lomeli
et al., 1994; Rula et al., 2008; Huang et al., 2012; Irimia et al.,
2012). Age-dependent increases have also been documented for
editing of small, non-coding RNA sequences, such as microR-
NAs (miRNAs), which typically bind to 3′ untranslated regions
(UTRs) of transcripts to signal their degradation (Ekdahl et al.,
2012). The potential for cross-talk between editing and gene
expression control mechanisms in regulating neuronal devel-
opment is exemplified with the case-study of miRNA cluster
379–410 (Ekdahl et al., 2012; Vesely et al., 2012). Here, edit-
ing in the critical seed regions of miRNA-381 and 376b prevents
binding to Pumilio 2 (Pum2) mRNA, which codes for a trans-
lational repressor serving to negatively regulate outgrowth of
neuronal dendrites. Consistent with this, developmental changes
in editing of these miRNAs correlated with increased expres-
sion of Pum2 (Ekdahl et al., 2012). The increasing discovery
of edits in non-coding sequences and the enrichment of some
ADARs in the nervous system make it tempting to postulate
that some observed tissue-specific expression patterns could
result from editing-dependent switches in miRNA seed regions
(Kawahara et al., 2007) or 3′-UTRs (Borchert et al., 2009), or
from ADAR-modulated processing of microRNAs (Yang et al.,
2006; Heale et al., 2009). Indeed, transcription profiling of the
brain of ADAR2 knockout mice indicates editing could regu-
late the expression of a large number of genes (Horsch et al.,
2011). Intriguingly, the genetic impact of A-to-I editing may be
underestimated from mouse models since a disproportionately
large amount of editing in humans also occurs in embedded
primate-specific Alu elements that likely function to regulate gene
expression (Maas, 2010).
CROSS-TALK BETWEEN A-TO-I EDITING AND
ALTERNATIVE SPLICING
In addition to interactions with gene-expression control mech-
anisms, cross-talk exists between A-to-I editing and alternative
splicing. Developmentally regulated, evolutionarily conserved
RNA editing of transcripts encoding the central nervous system
(CNS)-specific alternative splicing factor Nova1, reduces its
degradation by the proteasome thereby increasing Nova1 protein
levels (Irimia et al., 2012). Nova1 is expressed most in the ven-
tral spinal cord where it is essential for normal postnatal motor
function and notably regulates alternative splicing of multiple
inhibitory synaptic targets, including the major scaffold protein
gephyrin and the γ2 and α2 subunits of the GABAA and glycine
receptor ion channels, respectively (Jensen et al., 2000; Ule et al.,
2005). It remains to be determined how changes in editing of
endogenous Nova1 impact on the splicing of its targets, and
whether or not aberrant Nova1 editing could aggravate motor
neuron demise in sporadic amyotrophic lateral sclerosis (ALS);
a condition strongly associated with deficient ADAR2 expression
and GluA2 Q/R site editing (e.g., Hideyama et al., 2010, 2012).
Feedback regulation of editing exists and occurs directly via alter-
native splicing: ADAR2 regulates splicing of its own pre-mRNA
by creating a new splice acceptor site via its A-to-I editing activ-
ity. This causes an insertion of 47 nucleotides into the coding
sequence and a frameshift resulting in a truncated, catalytically
inactive protein (Rueter et al., 1999; Slavov and Gardiner, 2002;
Feng et al., 2006). Another interesting example demonstrating
the interaction of A-to-I editing with other RNA processes occurs
in the 5-HT2C receptor pre-mRNA. Here, an alternative splice
donor site (necessary for the coding of a full-length receptor
isoform) is silenced by a sequence element, which is weakened
either by RNA editing (Flomen et al., 2004) or by an editing-
independent mechanism that involves base-pairing of a small
nucleolar RNA (snoRNA) HBII-52 (Kishore and Stamm, 2006).
Consequently, neurons employ an unusualmechanism to regulate
the editing of full-length 5-HT2C receptors, which is significant
in maintaining a normal serotonergic system and its associ-
ated impact on cognition and behavior (Kishore and Stamm,
2006; Doe et al., 2009; Morabito et al., 2010). Editing-dependent
changes in splicing efficiency are also pivotal for AMPA-type glu-
tamate receptor subunits: the essential Q/R recoding event in the
GluA2 subunit, which controls ion channel calcium permeabil-
ity, is associated with more efficient pre-mRNA splicing (Brusa
et al., 1995). As a result, coupled editing and splicing ensures a
significantly high fraction of Q/R-edited GluA2 mRNA to tol-
erate modest changes in ADAR2 activity (Schoft et al., 2007;
Hideyama et al., 2012; Penn et al., 2013). Also in GluA2, a corre-
lation between R/G site editing and alternative splice site selection
appears to reflect a coupling associated with the homeostatic con-
trol of AMPA receptor biogenesis and function selectively in the
CA1 region of the hippocampus (Penn et al., 2012; Balik et al.,
2013).
NEURONAL ACTIVITY DRIVEN REGULATION OF RNA
EDITING
The prospect of activity-dependent changes in A-to-I editing
is an exciting recent development. There are various studies
describing changes in A-to-I editing in diseases including ALS,
epilepsy, and cancer, which mostly involve the GluA2 Q/R site
and are associated with Ca2+ influx through AMPA receptors
(Krestel et al., 2004; Maas et al., 2006). Another target is the sero-
tonin receptor; of which altered G-protein coupling efficiencies
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of the 5-HT2C receptor have been implicated in neuropsychi-
atric disorders (e.g., Gurevich et al., 2002; Bhansali et al., 2007;
O’Neil and Emeson, 2012). However, one feature underlying
many of these findings is that the pathological insults tend to
have a dramatic impact on neuronal activity (e.g., stress, kin-
dling, ischemia,). Some evidence points to a control of editing
fundamentally by neuronal signaling. Early reports showed that
serotonergic signaling via 5-HT2C receptor could regulate editing
of its own transcript to feedback onto the strength of recep-
tor G-protein coupling (Gurevich et al., 2002). The same group
later showed that the effect of a serotonin-selective reuptake
inhibitor could reverse stress-induced changes in 5-HT2C edit-
ing (Englander et al., 2005). Recent work in neuronal cultures
derived from cerebral cortex has demonstrated that pharmaco-
logically induced changes in neuronal activity can impact on
ADAR targets (Orlandi et al., 2011; Sanjana et al., 2012). Altering
neuronal activity in cultured hippocampal slices revealed anal-
ogous results, which turned out to be cell-type specific: editing
changes occurred in the CA1, but not in CA3 subfield, which
are composed of functionally and anatomically diverse neu-
ronal cell types (Balik et al., 2013). Therefore, A-to-I editing
has the capacity to fine-tune signaling in select neuronal cir-
cuitries. In two independent studies, chronic treatments lead to
similar changes in AMPA receptor R/G site editing and concur-
rent changes in ADAR2 expression levels (Sanjana et al., 2012;
Balik et al., 2013), which was also accompanied by regulation
of ADAR2 self-editing (Balik et al., 2013). Interestingly, a recent
study used a reporter based on the R/G site substrate to screen for
repressors of ADAR2-mediated editing and identified three RNA-
binding proteins (Tariq et al., 2013). The expression of two of
these candidates, the splicing factor SFRS9 and the RNA helicase
DDX15, was found to be regulated during mouse development
and also responded to activity manipulations in CA1 of cultured
hippocampal slices (Tariq et al., 2013). Binding of these factors
around the R/G site might inhibit editing either by competing
with ADAR2 for the substrate and/or by interacting directly with
editase to reduce its activity (Tariq et al., 2013). A characteriza-
tion of the physiological impact of editing site regulation in the
plasticity of neuronal functions as well as an elucidation of cell-
type/state specific changes in editing is now crucial and a very
exciting prospect.
MECHANISMS UNDERLYING ADAR REGULATION
The mechanisms underlying editing regulation are currently
unclear. These partly involve changes in ADAR levels (Balik
et al., 2013), which, in the case of ADAR2, are under neg-
ative feedback control (Feng et al., 2006). However, this will
depend on the efficiency of editing for a given ADAR sub-
strate and is less likely to be relevant for strongly edited sites
(Balik et al., 2013), such as the GluA2 Q/R site, for example.
The “strength” of editing varies during development (Lomeli
et al., 1994; Wahlstedt et al., 2009) and may be regulated in
a cell- or tissue-selective manner. High-throughput sequencing
data from cell lines imply overall low levels of editing (e.g.,
Bahn et al., 2012), but how this relates to editing levels in tis-
sue remains to be established. Earlier reports described changes
in ADAR expression levels during development (e.g., Paupard
et al., 2000; Hang et al., 2008), but have recently been challenged
as being responsible for observed editing site changes (Jacobs
et al., 2009; Wahlstedt et al., 2009). Over the last decade, a great
deal of emphasis has been placed on identifying and charac-
terizing ADAR isoforms arising from alternatively spliced exons
and transcription start sites (George et al., 2011). The vary-
ing activity of different ADAR isoforms has been described for
some editing sites and so has their regulated expression dur-
ing brain development (George et al., 2011), and the control of
ADAR1 transcript levels by microRNAs (miRNA-1, Lim et al.,
2005). The enigmatic, brain-specific (but non-catalytic) ADAR3
protein has been proposed to act in a dominant negative fash-
ion on targets of other ADARs in vitro (Chen et al., 2000), but
still little is known about its role and significance (Nishikura,
2010). More recently, protein structural studies have revealed
candidates for the modulation of ADAR protein function. The
ADAR2 catalytic domain contains a structurally integral inosi-
tol hexakisphosphate (IP6) required for efficient editing activity
(MacBeth et al., 2005). An intriguing postulation is that ele-
vated IP6 formed from phospholipase C (PLC) following 5-HT2C
activation might increase activity of nascent ADAR2 protein
and account for some of the feedback onto 5-HT2C recep-
tor editing (Schmauss et al., 2010). However, further work is
required to determine whether or not levels of IP6 in neurons
are rate-limiting for ADAR2 activity. Post-translational modifi-
cations have also been shown to regulate ADAR protein func-
tion or abundance, including SUMOylation, phosphorylation-
dependent propyl-isomerization and ubiquitination (Desterro
et al., 2005; Marcucci et al., 2011). Furthermore, the control of
dynamic associations of ADARs with subcellular compartments
has been proposed as a means to sequester functional ADARs
away from their targets in the nucleus. For example, induced
translocation of ADAR2 (and likely also the short p110 form
of ADAR1) from the nucleolus can increase activity at edit-
ing sites (Desterro et al., 2003; Sansam et al., 2003). However,
contextual examples for this type of regulation in the nervous
system remain elusive. Another example is the cytoplasmically
localized p150 form of ADAR1, which is transcribed from an
interferon-inducible promoter and can undergo regulated expres-
sion in some tissues, although not in the brain (Shtrichman
et al., 2002; George et al., 2005). Further clues from pathology
may reveal more candidate mechanisms relevant to physiological
ADAR control. One example is the potential ADAR2 regulation by
CA1-specific changes of cAMP-response element-binding protein
(CREB) activity that occur following transient ischemic insults
(Peng et al., 2006; Kitagawa, 2007). Consistent with these sug-
gestions, the ADAR2 promoter contains a CREB/AP-1 binding
site, which incidentally has shown necessary for ADAR2 regula-
tion in glucose-responsive pancreatic cells via the stress-activated
protein kinase JNK1 pathway (Yang et al., 2012). Furthermore,
a link between calcium signaling via L-type voltage-gated cal-
cium channels and activation of nuclear CREB might be key to
understanding activity-dependent changes in ADAR2 expression
(Wheeler et al., 2008; Balik et al., 2013). Challenges lie ahead
to identify and detail the potential routes of ADAR regulation
that are physiologically most relevant in different nervous system
contexts.
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HIGH-THROUGHPUT SEQUENCING AND EDITING IN
NON-CODING REGIONS
The lack of a clear signature for potential editing sites in gene
sequence was limiting for the identification of new RNA edit-
ing sites (Hoopengardner et al., 2003). Before high-throughput
sequencing techniques were available, a systematic search for
new sites was based on computational analysis of the available
databases containing genomic and transcriptional data. For
example, human expressed sequence tags (ESTs) and cDNA data
were aligned to genomic sequences to yield the discovery of four
new genes subjected to editing (Clutterbuck et al., 2005; Levanon
et al., 2005). However, these approaches were clearly limited as
evidenced by the fact that they failed to identify all previously
known editing sites. What these approaches did reveal though
is that recoding sites are just the tip of the iceberg and that the
majority of editing occurs in non-coding regions, which are vastly
enriched in Alu repetitive elements (Athanasiadis et al., 2004;
Blow et al., 2004; Kim et al., 2004; Levanon et al., 2004). These
findings explained the abundance of inosine in brainmRNA (Paul
and Bass, 1998) and confirmed experimental findings of edit-
ing in non-coding regions (Morse et al., 2002). Moreover, since
Alu elements are primate-specific and account for >10% of the
human genome, A-to-I substitutions are significantly more abun-
dant in primates (Eisenberg et al., 2005). The specific role of these
non-coding edits on nervous system operation has not been eluci-
dated. The high abundance of Alus, particularly in gene-enriched
regions, will increase the probability for oppositely oriented Alus
to anneal into dsRNA secondary structures thus serving as sub-
strates for editing. Alterations of the stability of edited dsRNA
structures will affect global RNAmetabolism via a link with RNA
interference (e.g., Bass, 2006). The advent of high-throughput
sequencing technology has led to further advances in our under-
standing of editing at the genome level and facilitated verification
of candidate sites (Li et al., 2009; Wahlstedt et al., 2009), has
revealed the interdependence or coupling of multiple editing sites
within a transcript (Ensterö et al., 2009), clarified the sequence
and structural determinants for editing (Bahn et al., 2012) and
enabled a comparison of the sites and frequency of edits between
genomes (Danecek et al., 2012). The ongoing efforts of consortia
like ENCODE and the 1000 Genomes Project will undoubtedly
advance these fronts further (Djebali et al., 2012; Park et al.,
2012).
OUTLOOK
As the discovery of new editing sites continues, so does the
need to understand their function, and regulation, in maintain-
ing normal neurophysiology and inmediating adaptability during
neuronal plasticity. It is increasingly apparent that the impact
of ADARs is widespread, diverse, and under dynamic control,
thus the need to dissect the functions of individual editing sites
is apparent. Animal models are going some way to achieve this
and their contribution to our current understanding have been
reviewed (e.g., Rula and Emeson, 2007 and references therein).
Recently, new manipulations have emerged that could improve
the throughput for investigating the functions of A-to-I editing
events, such as the use of substrate-specific helix-threading pep-
tides (Schirle et al., 2010) and steric antisense oligonucleotides
(Mizrahi et al., 2013; Penn et al., 2013). Recent advances in the
delivery of oligonucleotides using cell-penetrating peptides brings
researchers closer to applying these manipulations in vivo more
routinely (Järver et al., 2012; Moulton, 2012). In the future, these
tools together with the increasing capacity of high-throughput
resources might lead to therapeutic approaches that could cor-
rect defective editing associated with neurological diseases in
humans.
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